A new assay to evaluate microvesicle plasmin generation capacity: validation in disease with fibrinolysis imbalance

Archive ouverte

Cointe, Sylvie | Harti Souab, Karim | Bouriche, Tarik | Vallier, Loris | Bonifay, Amandine | Judicone, Coralie | Robert, Stephane | Armand, Romain | Poncelet, Philippe | Albanèse, Jacques | Dignat-George, Francoise | Lacroix, Romaric

Edité par CCSD ; Taylor & Francis -

International audience. Among extracellular vesicles, leukocyte-derived microvesicles (LMVs) have emerged as complex vesicular structures. Primarily identified as procoagulant entities, they were more recently ascribed to plasmin generation capacity (MV-PGC). The objectives of this work were (1) to develop a new hybrid bio-assay combining the specific isolation of LMVs and measurement of their PGC, and compare its performance to the original method based on centrifugation, (2) to validate MV-PGC in septic shock, combining increased levels of LMVs and fibrinolytic imbalance. Using plasma sample spiked with LMVs featuring different levels of PGC, we demonstrated that CD15-beads specifically extracted LMVs. The MV dependency of the test was demonstrated using electron microscopy, high speed centrifugation, nanofiltration and detergent-mediated solubilization and the MV-PGC specificity using plasmin-specific inhibitors, or antibodies blocking elastase or uPA. Thanks to a reaction booster (epsilon-ACA), we showed that the assay was more sensitive and reproducible than the original method. Moreover, it exhibited a good repeatability, inter-operator and inter-experiment reproducibility. The new immunomagnetic bio-assay was further validated in patients with septic shock. As a result, we showed that MV-PGC values were significantly lower in septic shock patients who died compared to patients who survived, both at inclusion and 24 h later (1.4 [0.8-3.0] vs 3.1 [1.7-18] A(405) x 10(-3)/min, p = 0.02; 1.4 [1-1.6] vs 5.2 [2.2-16] A(405) x 10(-3)/min, p = 0.004). Interestingly, combining both MV-PGC and PAI-1 in a ratio significantly improved the predictive value of PAI-1. This strategy, a hybrid capture bioassay to specifically measure LMV-PGC using for the first time, opens new perspectives for measuring subcellular fibrinolytic potential in clinical settings with fibrinolytic imbalance.

Suggestions

Du même auteur

Granulocyte microvesicles with a high plasmin generation capacity promote clot lysis and improve outcome in septic shock

Archive ouverte | Cointe, Sylvie | CCSD

International audience. Abstract Microvesicles (MVs) have previously been shown to exert profibrinolytic capacity, which is increased in patients with septic shock (SS) with a favorable outcome. We, therefore, hypot...

Increasing the sensitivity of the human microvesicle tissue factor activity assay

Archive ouverte | Vallier, Loris | CCSD

International audience. Introduction: The TF-FVIIa complex is the primary activator of coagulation. Elevated levels of microvesicle (MV) bearing tissue factor (TF)-dependent procoagulant activity are detectable in p...

A new hybrid immunocapture bioassay with improved reproducibility to measure tissue factor-dependent procoagulant activity of microvesicles from body fluids

Archive ouverte | Franco, Corentin | CCSD

International audience. Background: The procoagulant activity of tissue factor-bearing microvesicles (MV-TF) has been associated with the risk of developing venous thrombosis in cancer patients. However, MV-TF assay...

Chargement des enrichissements...